Physiol Rev Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Rev. 86: 849-899, 2006; doi:10.1152/physrev.00035.2005
0031-9333/06 $18.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (143)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deeley, R. G.
Right arrow Articles by Cole, S. P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deeley, R. G.
Right arrow Articles by Cole, S. P. C.

Transmembrane Transport of Endo- and Xenobiotics by Mammalian ATP-Binding Cassette Multidrug Resistance Proteins

Roger G. Deeley, Christopher Westlake and Susan P. C. Cole

Division of Cancer Biology and Genetics, Cancer Research Institute, and Departments of Biochemistry and of Pathology and Molecular Medicine, Queen’s University, Kingston, Ontario, Canada

Multidrug Resistance Proteins (MRPs), together with the cystic fibrosis conductance regulator (CFTR/ABCC7) and the sulfonylurea receptors (SUR1/ABCC8 and SUR2/ABCC9) comprise the 13 members of the human "C" branch of the ATP binding cassette (ABC) superfamily. All C branch proteins share conserved structural features in their nucleotide binding domains (NBDs) that distinguish them from other ABC proteins. The MRPs can be further divided into two subfamilies "long" (MRP1, -2, -3, -6, and -7) and "short" (MRP4, -5, -8, -9, and -10). The short MRPs have a typical ABC transporter structure with two polytropic membrane spanning domains (MSDs) and two NBDs, while the long MRPs have an additional NH2-terminal MSD. In vitro, the MRPs can collectively confer resistance to natural product drugs and their conjugated metabolites, platinum compounds, folate antimetabolites, nucleoside and nucleotide analogs, arsenical and antimonial oxyanions, peptide-based agents, and, under certain circumstances, alkylating agents. The MRPs are also primary active transporters of other structurally diverse compounds, including glutathione, glucuronide, and sulfate conjugates of a large number of xeno- and endobiotics. In vivo, several MRPs are major contributors to the distribution and elimination of a wide range of both anticancer and non-anticancer drugs and metabolites. In this review, we describe what is known of the structure of the MRPs and the mechanisms by which they recognize and transport their diverse substrates. We also summarize knowledge of their possible physiological functions and evidence that they may be involved in the clinical drug resistance of various forms of cancer.





This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
Y. Zhang, T. Zhao, W. Li, and M. Vore
The 5'-Untranslated Region of Multidrug Resistance Associated Protein 2 (MRP2; ABCC2) Regulates Downstream Open Reading Frame Expression through Translational Regulation
Mol. Pharmacol., February 1, 2010; 77(2): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
Microbiol. Mol. Biol. Rev.Home page
C. M. Paumi, M. Chuk, J. Snider, I. Stagljar, and S. Michaelis
ABC Transporters in Saccharomyces cerevisiae and Their Interactors: New Technology Advances the Biology of the ABCC (MRP) Subfamily
Microbiol. Mol. Biol. Rev., December 1, 2009; 73(4): 577 - 593.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. L. H. Vlaming, A. van Esch, Z. Pala, E. Wagenaar, K. van de Wetering, O. van Tellingen, and A. H. Schinkel
Abcc2 (Mrp2), Abcc3 (Mrp3), and Abcg2 (Bcrp1) are the main determinants for rapid elimination of methotrexate and its toxic metabolite 7-hydroxymethotrexate in vivo
Mol. Cancer Ther., December 1, 2009; 8(12): 3350 - 3359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. K. Jackson, J. Ren, and Z. Mi
Extracellular 2',3'-cAMP Is a Source of Adenosine
J. Biol. Chem., November 27, 2009; 284(48): 33097 - 33106.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. van de Ven, R. Oerlemans, J. W. van der Heijden, G. L. Scheffer, T. D. de Gruijl, G. Jansen, and R. J. Scheper
ABC drug transporters and immunity: novel therapeutic targets in autoimmunity and cancer
J. Leukoc. Biol., November 1, 2009; 86(5): 1075 - 1087.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-L. Fu, Y. Meng, E. Ordonez, A. F. Villadangos, H. Bhattacharjee, J. A. Gil, L. M. Mateos, and B. P. Rosen
Properties of Arsenite Efflux Permeases (Acr3) from Alkaliphilus metalliredigens and Corynebacterium glutamicum
J. Biol. Chem., July 24, 2009; 284(30): 19887 - 19895.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
J. N. Orina, A. M. Calcagno, C.-P. Wu, S. Varma, J. Shih, M. Lin, G. Eichler, J. N. Weinstein, Y. Pommier, S. V. Ambudkar, et al.
Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database
Mol. Cancer Ther., July 1, 2009; 8(7): 2057 - 2066.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
B. Marquez, N. E. Caceres, M.-P. Mingeot-Leclercq, P. M. Tulkens, and F. Van Bambeke
Identification of the Efflux Transporter of the Fluoroquinolone Antibiotic Ciprofloxacin in Murine Macrophages: Studies with Ciprofloxacin-Resistant Cells
Antimicrob. Agents Chemother., June 1, 2009; 53(6): 2410 - 2416.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. M. Pelis, M. Shahidullah, S. Ghosh, M. Coca-Prados, S. H. Wright, and N. A. Delamere
Localization of Multidrug Resistance-Associated Protein 2 in the Nonpigmented Ciliary Epithelium of the Eye
J. Pharmacol. Exp. Ther., May 1, 2009; 329(2): 479 - 485.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. E. Bram, Y. Adar, N. Mesika, M. Sabisz, A. Skladanowski, and Y. G. Assaraf
Structural Determinants of Imidazoacridinones Facilitating Antitumor Activity Are Crucial for Substrate Recognition by ABCG2
Mol. Pharmacol., May 1, 2009; 75(5): 1149 - 1159.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Ren, Z. Mi, N. A. Stewart, and E. K. Jackson
Identification and Quantification of 2',3'-cAMP Release by the Kidney
J. Pharmacol. Exp. Ther., March 1, 2009; 328(3): 855 - 865.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. Lemos, I. Kathmann, E. Giovannetti, J. A.M. Belien, G. L. Scheffer, C. Calhau, G. Jansen, and G. J. Peters
Cellular folate status modulates the expression of BCRP and MRP multidrug transporters in cancer cell lines from different origins
Mol. Cancer Ther., March 1, 2009; 8(3): 655 - 664.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
A. M. Naar and J. K. Thakur
Nuclear receptor-like transcription factors in fungi
Genes & Dev., February 15, 2009; 23(4): 419 - 432.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Conseil, A. J. Rothnie, R. G. Deeley, and S. P. C. Cole
Multiple Roles of Charged Amino Acids in Cytoplasmic Loop 7 for Expression and Function of the Multidrug and Organic Anion Transporter MRP1 (ABCC1)
Mol. Pharmacol., February 1, 2009; 75(2): 397 - 406.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
J. Aittoniemi, C. Fotinou, T. J Craig, H. de Wet, P. Proks, and F. M Ashcroft
SUR1: a unique ATP-binding cassette protein that functions as an ion channel regulator
Phil Trans R Soc B, January 27, 2009; 364(1514): 257 - 267.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Hopper-Borge, X. Xu, T. Shen, Z. Shi, Z.-S. Chen, and G. D. Kruh
Human Multidrug Resistance Protein 7 (ABCC10) Is a Resistance Factor for Nucleoside Analogues and Epothilone B
Cancer Res., January 1, 2009; 69(1): 178 - 184.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Yoshioka, H. Sagara, F. Takahashi, N. Harada, K. Nishio, A. Mori, H. Ushio, K. Shimizu, T. Okada, M. Ota, et al.
Role of multidrug resistance-associated protein 1 in the pathogenesis of allergic airway inflammation
Am J Physiol Lung Cell Mol Physiol, January 1, 2009; 296(1): L30 - L36.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
C. E. Grant, M. Gao, M. K. DeGorter, S. P. C. Cole, and R. G. Deeley
Structural Determinants of Substrate Specificity Differences between Human Multidrug Resistance Protein (MRP) 1 (ABCC1) and MRP3 (ABCC3)
Drug Metab. Dispos., December 1, 2008; 36(12): 2571 - 2581.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. Rothnie, G. Conseil, A. Y. T. Lau, R. G. Deeley, and S. P. C. Cole
Mechanistic Differences between GSH Transport by Multidrug Resistance Protein 1 (MRP1/ABCC1) and GSH Modulation of MRP1-Mediated Transport
Mol. Pharmacol., December 1, 2008; 74(6): 1630 - 1640.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. A. K. El-Sheikh, J. J. M. W. van den Heuvel, E. Krieger, F. G. M. Russel, and J. B. Koenderink
Functional Role of Arginine 375 in Transmembrane Helix 6 of Multidrug Resistance Protein 4 (MRP4/ABCC4)
Mol. Pharmacol., October 1, 2008; 74(4): 964 - 971.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
C. C. Bridges, L. Joshee, and R. K. Zalups
MRP2 and the DMPS- and DMSA-Mediated Elimination of Mercury in TR- and Control Rats Exposed to Thiol S-Conjugates of Inorganic Mercury
Toxicol. Sci., September 1, 2008; 105(1): 211 - 220.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. E. Bandler, C. J. Westlake, C. E. Grant, S. P. C. Cole, and R. G. Deeley
Identification of Regions Required for Apical Membrane Localization of Human Multidrug Resistance Protein 2
Mol. Pharmacol., July 1, 2008; 74(1): 9 - 19.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Md. T. Hoque and S. P.C. Cole
Down-regulation of Na+/H+ Exchanger Regulatory Factor 1 Increases Expression and Function of Multidrug Resistance Protein 4
Cancer Res., June 15, 2008; 68(12): 4802 - 4809.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Luckenbach and D. Epel
ABCB- and ABCC-type transporters confer multixenobiotic resistance and form an environment-tissue barrier in bivalve gills
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1919 - R1929.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T.-Y. Chen and T.-C. Hwang
CLC-0 and CFTR: Chloride Channels Evolved From Transporters
Physiol Rev, April 1, 2008; 88(2): 351 - 387.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M. Rius, J. Hummel-Eisenbeiss, and D. Keppler
ATP-Dependent Transport of Leukotrienes B4 and C4 by the Multidrug Resistance Protein ABCC4 (MRP4)
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 86 - 94.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. V. Erives, S. S. Lau, and T. J. Monks
Accumulation of Neurotoxic Thioether Metabolites of 3,4-({+/-})-Methylenedioxymethamphetamine in Rat Brain
J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 284 - 291.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Z. P. Lin, Y.-L. Zhu, D. R. Johnson, K. P. Rice, T. Nottoli, B. C. Hains, J. McGrath, S. G. Waxman, and A. C. Sartorelli
Disruption of cAMP and Prostaglandin E2 Transport by Multidrug Resistance Protein 4 Deficiency Alters cAMP-Mediated Signaling and Nociceptive Response
Mol. Pharmacol., January 1, 2008; 73(1): 243 - 251.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C.-P. Wu, S. Shukla, A. M. Calcagno, M. D. Hall, M. M. Gottesman, and S. V. Ambudkar
Evidence for dual mode of action of a thiosemicarbazone, NSC73306: a potent substrate of the multidrug resistance linked ABCG2 transporter
Mol. Cancer Ther., December 1, 2007; 6(12): 3287 - 3296.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Li, Q. Pan, W. Han, Z. Liu, L. Li, and X. Hu
Schisandrin B Prevents Doxorubicin-Induced Cardiotoxicity via Enhancing Glutathione Redox Cycling
Clin. Cancer Res., November 15, 2007; 13(22): 6753 - 6760.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
E. Currie, B. King, A. L. Lawrenson, L. K. Schroeder, A. M. Kershner, and G. J. Hermann
Role of the Caenorhabditis elegans Multidrug Resistance Gene, mrp-4, in Gut Granule Differentiation
Genetics, November 1, 2007; 177(3): 1569 - 1582.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
I. J. Letourneau, A. J. Slot, R. G. Deeley, and S. P. C. Cole
Mutational Analysis of a Highly Conserved Proline Residue in MRP1, MRP2, and MRP3 Reveals a Partially Conserved Function
Drug Metab. Dispos., August 1, 2007; 35(8): 1372 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Willoughby and D. M. F. Cooper
Organization and Ca2+ Regulation of Adenylyl Cyclases in cAMP Microdomains
Physiol Rev, July 1, 2007; 87(3): 965 - 1010.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Filipits, V. Haddad, K. Schmid, A. Huynh, A. Dunant, F. Andre, E. Brambilla, R. Stahel, J.-P. Pignon, J.-C. Soria, et al.
Multidrug Resistance Proteins Do Not Predict Benefit of Adjuvant Chemotherapy in Patients with Completely Resected Non-Small Cell Lung Cancer: International Adjuvant Lung Cancer Trial Biologic Program
Clin. Cancer Res., July 1, 2007; 13(13): 3892 - 3898.
[Abstract] [Full Text] [PDF]


Home page
Eukaryot CellHome page
P. Leprohon, D. Legare, I. Girard, B. Papadopoulou, and M. Ouellette
Modulation of Leishmania ABC Protein Gene Expression through Life Stages and among Drug-Resistant Parasites.
Eukaryot. Cell, October 1, 2006; 5(10): 1713 - 1725.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. Sarkadi, L. Homolya, G. Szakacs, and A. Varadi
Human Multidrug Resistance ABCB and ABCG Transporters: Participation in a Chemoimmunity Defense System.
Physiol Rev, October 1, 2006; 86(4): 1179 - 1236.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.